RCUS
Arcus Biosciences
$18.39
+$0.25 (+1.38%)Oct 28, 2026
Key metrics
The numbers that frame RCUS today
- Market cap
- $2.34B
- Gross margin
- 100%
- EV / Sales
- 19.6
- ROIC
- -65.4%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $17.43
- 52wk High
- $31.74
Growth
Revenue and earnings trend for RCUS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RCUS
Is Arcus Biosciences a good buy?
Hold. Arcus Biosciences has excellent momentum, but weak quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Arcus Biosciences is selling at a very high price.
What is the market capitalization of RCUS?
Arcus Biosciences's market capitalization is $2.34B.
What is the 52-week high for RCUS stock?
The 52-week high for Arcus Biosciences is $31.74. The current close of $18.39 is 42.1% below that high.
What is the 52-week low for RCUS stock?
The 52-week low for Arcus Biosciences is $17.43. The current close of $18.39 is 5.5% above that low.
Does RCUS stock pay dividends?
Arcus Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for RCUS?
Arcus Biosciences's Debt / Equity ratio is 0.22.